Aiken Jason W 4

What Happened Jason W. Aiken, a director of QXO, exercised/converted 12,111 derivative shares on May 5, 2026 and simultaneously disposed of those 12,111 shares (both reported at $0.00). On the same date he was also granted 9,274 restricted stock units (RSUs) reported as a derivative acquisition (also $0.00). The exercise/conversion and immediate disposition indicate the shares were converted and sold/removed the same day; the RSUs are an award that will convert to common stock only upon settlement.

Key Details

• Transaction date(s): May 5, 2026 (reported on Form 4 filed May 7, 2026).
• Prices: All transactions reported at $0.00 per share (derivative/award reporting).
• Shares: 12,111 exercised/converted and 12,111 disposed; 9,274 RSUs granted.
• Shares owned after transaction: Not stated in the excerpt — see the full Form 4 for total beneficial ownership.
• Notable footnotes:
  • F1: Each RSU equals a contingent right to one share upon settlement.
  • F2: The newly granted RSUs vest in full at the issuer’s 2027 Annual Meeting, subject to continued service as a director.
  • F3: Separately, RSUs granted May 12, 2025 vested and settled at the issuer’s 2026 Annual Meeting.
• Timeliness: Filing appears timely (reported May 7 for May 5 transactions); no late filing indicated.

Context

• The paired exercise/conversion (M) entries showing both acquisition and disposition of 12,111 shares on the same date typically reflect an exercise followed by an immediate sale or conversion/transfer — commonly a cashless-like outcome — but the Form 4 shows $0 consideration, so check the full filing for settlement details.
• The 9,274 RSUs are an award, not immediately tradable stock; they convert to shares only upon vesting/settlement per the footnote conditions.
• This reporting is factual disclosure of insider activity and should not be taken as a statement of intent or investment advice. See the full Form 4 (Accession 0001236275-26-000007) for complete holdings and transaction metadata.